Multifunctional nanoplatform delivering carbon monoxide and cysteine protease inhibitor to mitochondria under NIR light enhanced synergistic anticancer efficacy

Qi Tang,Jing Liu,Lu An,Hai-Lin Zhang,Yi Wang,Bing Ren,Jin-Gang Liu,Chengbin Wang,Shiping Yang
DOI: https://doi.org/10.1039/d2nr01122k
IF: 6.7
2022-05-27
Nanoscale
Abstract:Photoactivated chemotherapy has attracted widespread attention due to its ability to circumvent the shortcomings of hypoxia in tumor tissues compared with traditional photodynamic therapy. In this work, a novel multifunctional nanoplatform (1), Ru-inhibitor@TPPMnCO@N-GQDs, is designed and prepared, which is capable of mitochondria-targeted co-delivery of cysteine protease inhibitor and carbon monoxide (CO) stimulated by 808 nm near infrared (NIR) laser. Nanoplatform (1) is prepared by covalent attachment of a mitochondria-targeted CO donor (TPPMnCO) and a Ru(II)-caged cysteine protease inhibitor (Ru-inhibitor) on the surface of a fluorescent N-doped graphene quantum dots (N-GQDs). Nanoplatform (1) preferentially accumulates in the mitochondria of cancer cells and instantly delivers CO and cysteine protease inhibitor upon 808 nm NIR light irradiation, thus damaging mitochondria and leading to significant in vitro and vivo anticancer efficacy. In addition, nanoplatform (1) has good biocompatibility and do not exert any toxic side effects on the mice during the period of treatment. The targeted subcellular mitochondrial co-delivery of CO and cysteine protease inhibitor may provide new insights for CO and enzyme inhibitor combined therapies for cancer treatment.
materials science, multidisciplinary,physics, applied,nanoscience & nanotechnology,chemistry
What problem does this paper attempt to address?